XELIRI compared with FOLFIRI as a second-line treatment in patients with metastatic colorectal cancer
暂无分享,去创建一个
Songnian Hu | C. Cui | Chang Shu | Yi Yang | Junbao Liu | S. Shi | Zhujun Shao | Ting Yang | Nan Wang
暂无分享,去创建一个
Songnian Hu | C. Cui | Chang Shu | Yi Yang | Junbao Liu | S. Shi | Zhujun Shao | Ting Yang | Nan Wang